Dr Gregory Paul Gilmet, in Minneapolis, MN - Allergy & Immunology

Dr Gregory Paul Gilmet, is a Allergy & Immunology physician based in Minneapolis, Minnesota. Dr Gregory Paul Gilmet is licensed to practice in Minnesota (license number 41471) and his current practice location is 401 Harding St Ne # 100, Minneapolis, Minnesota. He can be reached at his office (for appointments etc.) via phone at (888) 709-9344.

NPI number for Dr Gregory Paul Gilmet is 1083036222 and his current mailing address is 401 Harding St Ne # 100, Minneapolis, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1083036222.

Contact Information

	Dr Gregory Paul Gilmet,
	401 Harding St Ne # 100, Minneapolis, MN 55413-2801
	(888) 709-9344
	Not Available

Physician's Profile

Full Name	Dr Gregory Paul Gilmet
Gender	Male
Speciality	Allergy & Immunology
Location	401 Harding St Ne # 100, Minneapolis, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1083036222
Provider Enumeration Date: 01/07/2014
Last Update Date: 07/21/2022

Medical Identifiers

Medical identifiers for Dr Gregory Paul Gilmet such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083036222	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207K00000X	Allergy & Immunology	41471 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gregory Paul Gilmet is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gregory Paul Gilmet, 401 Harding St Ne # 100, Minneapolis, MN 55413-2801 Ph: (888) 709-9344	Dr Gregory Paul Gilmet, 401 Harding St Ne # 100, Minneapolis, MN 55413-2801 Ph: (888) 709-9344

News Archive

Exposure to SARS-CoV-2 can induce virus-specific T cell responses without seroconversion

A new study by researchers at Strasbourg University Hospital and published on the preprint server medRxiv* in June 2020 shows that COVID-19 antibody responses may sometimes be lacking following exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could lead to a significant underestimation of the number of infections and the number of individuals who have achieved immunity.

Dana-Farber Cancer Institute and Sanford-Burnham Medical Research Institute sign license agreement with Genentech

Dana-Farber Cancer Institute and the Sanford-Burnham Medical Research Institute have signed a license agreement with Genentech, a wholly owned member of the Roche group, and Roche, that grants the companies exclusive rights to manufacture, develop and market human monoclonal antibodies to treat and protect against group 1 influenza viruses. These viruses include the strains for the current seasonal and H1N1 influenzas. Genentech and Roche also have a non-exclusive right to manufacture, develop and market diagnostic tests for group 1 influenza.

Study examines effects of caregiving

A new study from the USC Davis School of Gerontology found that caregivers of different ethnicities showed few negative mental or physical health effects as a result of tending to a family member with dementia.

Salix anticipates receipt of FDA's CRL for XIFAXAN 550 mg sNDA

Salix Pharmaceuticals, Ltd. today announced that based on a telephone conversation with the U.S. Food and Drug Administration held last evening, the Company anticipates receiving a Complete Response Letter on or before the March 7, 2011 PDUFA goal date for the supplemental New Drug Application for XIFAXAN 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating.

Digital Pathology Association has another Gold Sponsor: Sunquest Information Systems

Sunquest Information Systems, Inc., a market leader in laboratory and diagnostic information systems, today announced that it is a Founding Gold Sponsor of the Digital Pathology Association (DPA), a non-profit organization committed to the advancement of digital pathology applications in healthcare. The goals of the DPA include supporting digital pathology education initiatives, defining best practices, influencing standards and interfaces, organizing an annual conference that addresses diverse needs within the industry, and more.

Allergy & Immunology Doctors in Minneapolis, MN

Dr. Philip C. Halverson, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 825 Nicollet Mall, Suite 1149, Minneapolis, MN 55402 Phone: 612-338-3333 Fax: 612-349-3838
Dr. Nancy Lorene Ott, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2535 University Ave Se, Minneapolis, MN 55414 Phone: 612-672-2350
Rolf N Sigford, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2220 Riverside Ave S, Mail Stop 31700a, Minneapolis, MN 55454 Phone: 612-371-1600 Fax: 612-371-1732
Joshua M Dorn, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 715 S 8th St, Minneapolis, MN 55404 Phone: 612-873-6963
Masanao Takahashi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2220 Riverside Ave, Mail Stop 31700a, Minneapolis, MN 55454 Phone: 612-371-1600 Fax: 612-371-1732
Dr. Hannelore August Brucker, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 4010 W 65th St, Ste 221, Minneapolis, MN 55435 Phone: 952-926-7630 Fax: 952-926-2116

Dr Gregory Paul Gilmet, - Allergy & Immunology in Minneapolis, MN